fr

EN DE

fr

EN DE

Publications

2075 PUBLICATIONS - effacer la recherche

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

2021

Frontiers in oncology

Carinato H

Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients.

2021

Frontiers in oncology

Taillandier L

What Does Quality of Care Mean in Lower-Grade Glioma Patients: A Precision Molecular-Based Management of the Tumor or an Individualized Medicine Centered on Patient's Choices?

2021

Frontiers in cell and developmental biology

Neyrinck-Leglantier D

ZO-1 Intracellular Localization Organizes Immune Response in Non-Small Cell Lung Cancer.

2020

Genes & cancer

Grandvallet C

Autophagy is associated with a robust specific transcriptional signature in breast cancer subtypes.

2020

Biomolecules

Bretaudeau C

AG-9, an Elastin-Derived Peptide, Increases In Vitro Oral Tongue Carcinoma Cell Invasion, through an Increase in MMP-2 Secretion and MT1-MMP Expression, in a RPSA-Dependent Manner.

2020

International journal of surgery case reports

Marchand Crety C

Primary gastric synovial sarcoma: A case report and literature review.

2020

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Khadige M

[Lung cancer and pulmonary metastasis treated by stereotactic radiosurgery: Evaluation of the relevance of realisation of 3 4D CT by the RPM technique].

2020

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Taïeb J

Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial.

2020

Bulletin du cancer

Schraub S

[Impact of patient testimony in the education of medicine and pharmacy students].

2020

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Evrard C

PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer.